HK1043945B - 含氯雷他定和偽麻黃碱的藥物膠囊組合物 - Google Patents
含氯雷他定和偽麻黃碱的藥物膠囊組合物Info
- Publication number
- HK1043945B HK1043945B HK02105460.8A HK02105460A HK1043945B HK 1043945 B HK1043945 B HK 1043945B HK 02105460 A HK02105460 A HK 02105460A HK 1043945 B HK1043945 B HK 1043945B
- Authority
- HK
- Hong Kong
- Prior art keywords
- pseudoephedrine
- pellets
- pharmaceutically acceptable
- loratadine
- pharmaceutical capsule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19990005873 | 1999-02-23 | ||
PCT/KR2000/000130 WO2000050015A1 (en) | 1999-02-23 | 2000-02-18 | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1043945A1 HK1043945A1 (en) | 2002-10-04 |
HK1043945B true HK1043945B (zh) | 2005-02-08 |
Family
ID=19574799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02105460.8A HK1043945B (zh) | 1999-02-23 | 2002-07-24 | 含氯雷他定和偽麻黃碱的藥物膠囊組合物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US6251427B1 (zh) |
EP (1) | EP1154762B1 (zh) |
JP (1) | JP3645816B2 (zh) |
CN (1) | CN1161112C (zh) |
AT (1) | ATE253354T1 (zh) |
AU (1) | AU2697100A (zh) |
DE (1) | DE60006362T2 (zh) |
ES (1) | ES2204517T3 (zh) |
HK (1) | HK1043945B (zh) |
WO (1) | WO2000050015A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506783B1 (en) * | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
WO2001021161A2 (en) * | 1999-09-21 | 2001-03-29 | Schering Corporation | Use of desloratadine for treating allergic and inflammatory conditions |
CN1518448A (zh) * | 2001-06-20 | 2004-08-04 | ���鹫˾ | 用于治疗鼻充血和鼻塞的抗组胺剂 |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
MXPA04009968A (es) | 2002-04-09 | 2004-12-13 | Flamel Tech Sa | Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s). |
US20040033257A1 (en) * | 2002-05-30 | 2004-02-19 | Strides Inc. | Pharmaceutical formulation in a drug delivery system and process for preparing the same |
PE20050202A1 (es) * | 2003-05-12 | 2005-05-14 | Dasan Medichen Co Ltd | La composicion farmaceutica de liberacion controlada de pseudoefredina o sus sales |
DK1660047T3 (en) | 2003-08-13 | 2014-03-10 | Biocon Ltd | MICROPARTICALLY FATIC ACID SALT SOLID DOSAGE FORMS FOR THERAPEUTIC AGENTS |
CA2537477C (en) * | 2003-09-03 | 2013-05-14 | Boehringer Ingelheim International Gmbh | Capsules containing active substance pellets with different release profiles |
US20070190125A1 (en) | 2004-03-03 | 2007-08-16 | Constantine Georgiades | Positioning feature for aiding use of film or strip product |
PE20080313A1 (es) * | 2006-06-01 | 2008-04-10 | Schering Corp | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas |
NZ573173A (en) | 2006-06-01 | 2012-03-30 | Msd Consumer Care Inc | Phenylephrine pharmaceutical formulation and compositions for colonic absorption |
BRPI0712960A2 (pt) * | 2006-06-30 | 2012-04-17 | Teva Pharma | compostos farmacêuticos que incluem uma combinação de piperidinoalcanol e descongestionante |
JP5668317B2 (ja) * | 2009-04-24 | 2015-02-12 | 大正製薬株式会社 | プソイドエフェドリン含有製剤粒子 |
US20110218209A1 (en) * | 2010-03-06 | 2011-09-08 | Paul Daniel Yered | Nutrient delievry drug composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2738303A (en) * | 1952-07-18 | 1956-03-13 | Smith Kline French Lab | Sympathomimetic preparation |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
KR960006917A (ko) | 1994-08-13 | 1996-03-22 | 김태훈 | 테르페나딘과-염산슈도에페드린 복합 펠렛(pellet) 조성물 |
WO1998018470A1 (en) * | 1996-10-31 | 1998-05-07 | Schering Corporation | Composition, for the treatment of asthma, containing loratadine and a decongestant |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
-
2000
- 2000-02-18 WO PCT/KR2000/000130 patent/WO2000050015A1/en active IP Right Grant
- 2000-02-18 CN CNB008041857A patent/CN1161112C/zh not_active Expired - Fee Related
- 2000-02-18 AT AT00905431T patent/ATE253354T1/de not_active IP Right Cessation
- 2000-02-18 EP EP00905431A patent/EP1154762B1/en not_active Expired - Lifetime
- 2000-02-18 JP JP2000600627A patent/JP3645816B2/ja not_active Expired - Fee Related
- 2000-02-18 AU AU26971/00A patent/AU2697100A/en not_active Abandoned
- 2000-02-18 DE DE60006362T patent/DE60006362T2/de not_active Expired - Fee Related
- 2000-02-18 ES ES00905431T patent/ES2204517T3/es not_active Expired - Lifetime
- 2000-02-22 US US09/507,995 patent/US6251427B1/en not_active Expired - Fee Related
-
2002
- 2002-07-24 HK HK02105460.8A patent/HK1043945B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60006362D1 (de) | 2003-12-11 |
JP2002537323A (ja) | 2002-11-05 |
DE60006362T2 (de) | 2004-08-26 |
WO2000050015A1 (en) | 2000-08-31 |
ES2204517T3 (es) | 2004-05-01 |
CN1161112C (zh) | 2004-08-11 |
HK1043945A1 (en) | 2002-10-04 |
JP3645816B2 (ja) | 2005-05-11 |
CN1341014A (zh) | 2002-03-20 |
AU2697100A (en) | 2000-09-14 |
US6251427B1 (en) | 2001-06-26 |
ATE253354T1 (de) | 2003-11-15 |
EP1154762B1 (en) | 2003-11-05 |
EP1154762A1 (en) | 2001-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1043945A1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine. | |
IL111647A (en) | Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation | |
EP2266542A3 (en) | Controlled release nanoparticulate compositions | |
CA2264238A1 (fr) | Forme galenique a liberation prolongee de milnacipran | |
UA88056C2 (uk) | Дозована форма оксикодону, що вводиться один раз на день | |
EP2036558A3 (en) | Orally administrable opioid formulations having extended duration of effect | |
AU7143796A (en) | Controlled release matrix for pharmaceuticals | |
NZ311145A (en) | Controlled release formulations containing a poorly soluble drug in a solid dispersion with a hydrophilic poloxamer | |
IE831799L (en) | Controlled release naproxen and naproxen sodium tablets. | |
IL119684A (en) | Long lasting release nifedipine preparation in form of press coated tablets | |
CA2126611A1 (en) | Opiod Formulations Having Extended Controlled Release | |
DK0923934T3 (da) | Modified release-matrixformulering af cefaclor og cephalexin | |
ES8502333A1 (es) | Un procedimiento para la preparacion de una tableta farmaceutica | |
WO2004108162A3 (en) | Controlled release pharmaceutical composition | |
CZ225596A3 (en) | Film-coated tablets of paracetamol and domperidon | |
PT885014E (pt) | Composicoes farmaceuticas contendo polimeros orto ester tamponados | |
CA2240281A1 (en) | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases | |
DE60035579D1 (de) | Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme | |
WO2006011001A3 (en) | Controlled release compositions of divalproex sodium | |
CA2243988A1 (en) | Pharmaceutical compositions containing buffered ortho ester polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080218 |